ROCKMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ROCKMED
Largest movements
- Receivables within one year -€1.1m
down €1.1m (-30.0%), from €3.6m to €2.5m
of which Trade receivables: -€1.2m
- Stocks and contracts +€364,021
up €364,021 (+13.0%), from €2.8m to €3.2m
- Other debts -€885,383
down €885,383 (-46.8%), from €1.9m to €1.0m
- Profit (loss) carried forward +€413,207
up €413,207 (+25.2%), from €1.6m to €2.1m
- Trade debts -€234,823
down €234,823 (-17.4%), from €1.3m to €1.1m
- Accrued charges and deferred income +€121,654
up €121,654 (+39.8%), from €305,723 to €427,376
- Advances received -€68,353
no longer reported in 2025 (was €68,353)
- Write-downs -€54,648
down €54,648, from €39,002 to -€15,646
- Taxes +€38,771
up €38,771 (+23.5%), from €165,224 to €203,995
- Financial charges +€25,062
up €25,062 (+34.6%), from €72,424 to €97,486
- Staff costs -€18,486
down €18,486 (-1.8%), from €1.0m to €995,870
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,687,972 | €5,983,543 | -€704,429 | -10.5% |
| Fixed assets | 21/28 | €81,587 | €44,106 | -€37,481 | -45.9% |
| Tangible fixed assets | 22/27 | €81,587 | €38,434 | -€43,153 | -52.9% |
| Furniture and vehicles | 24 | €20,200 | €19,353 | -€847 | -4.2% |
| Other tangible fixed assets | 26 | €61,388 | €19,081 | -€42,306 | -68.9% |
| Financial fixed assets | 28 | - | €5,672 | +€5,672 | |
| Current assets | 29/58 | €6,606,385 | €5,939,437 | -€666,948 | -10.1% |
| Stocks and contracts in progress | 3 | €2,807,962 | €3,171,983 | +€364,021 | +13.0% |
| Stocks | 30/36 | €2,807,962 | €3,171,983 | +€364,021 | +13.0% |
| Amounts receivable within one year | 40/41 | €3,568,558 | €2,499,336 | -€1.1m | -30.0% |
| Trade receivables | 40 | €3,520,519 | €2,327,825 | -€1.2m | -33.9% |
| Other amounts receivable | 41 | €48,039 | €171,511 | +€123,472 | +257% |
| Cash at bank and in hand | 54/58 | €206,254 | €237,800 | +€31,546 | +15.3% |
| Deferred charges and accrued income | 490/1 | €23,611 | €30,318 | +€6,707 | +28.4% |
| Total equity and liabilities | 10/49 | €6,687,972 | €5,983,543 | -€704,429 | -10.5% |
| Equity | 10/15 | €2,801,122 | €3,214,329 | +€413,207 | +14.8% |
| Contributions | 10/11 | €1,161,002 | €1,161,002 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,640,120 | €2,053,327 | +€413,207 | +25.2% |
| Amounts payable | 17/49 | €3,886,851 | €2,769,214 | -€1.1m | -28.8% |
| Amounts payable within one year | 42/48 | €3,581,128 | €2,341,838 | -€1.2m | -34.6% |
| Financial debts | 43 | €65,098 | - | -€65,098 | |
| Credit institutions | 430/8 | €65,098 | - | -€65,098 | |
| Trade debts | 44 | €1,349,825 | €1,115,002 | -€234,823 | -17.4% |
| Suppliers | 440/4 | €1,349,825 | €1,115,002 | -€234,823 | -17.4% |
| Advances received on contracts in progress | 46 | €68,353 | - | -€68,353 | |
| Taxes, remuneration and social security | 45 | €206,161 | €220,528 | +€14,367 | +7.0% |
| Taxes | 450/3 | €89,305 | €97,507 | +€8,201 | +9.2% |
| Remuneration and social security | 454/9 | €116,855 | €123,021 | +€6,165 | +5.3% |
| Other amounts payable | 47/48 | €1,891,691 | €1,006,308 | -€885,383 | -46.8% |
| Accrued charges and deferred income | 492/3 | €305,723 | €427,376 | +€121,654 | +39.8% |
| Remuneration, social security and pensions | 62 | €1,014,356 | €995,870 | -€18,486 | -1.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €24,674 | €15,942 | -€8,732 | -35.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €39,002 | -€15,646 | -€54,648 | |
| Other operating charges | 640/8 | €25,755 | €29,539 | +€3,784 | +14.7% |
| Non-recurring operating charges | 66A | €124 | - | -€124 | |
| Gross operating margin | 9900 | €1,753,316 | €1,740,393 | -€12,923 | -0.7% |
| Operating profit (loss) | 9901 | €649,404 | €714,688 | +€65,284 | +10.1% |
| Financial charges | 65/66B | €72,424 | €97,486 | +€25,062 | +34.6% |
| Recurring financial charges | 65 | €72,424 | €97,486 | +€25,062 | +34.6% |
| Profit (loss) for the period before taxes | 9903 | €576,980 | €617,202 | +€40,222 | +7.0% |
| Income taxes | 67/77 | €165,224 | €203,995 | +€38,771 | +23.5% |
| Profit (loss) for the period | 9904 | €411,756 | €413,207 | +€1,451 | +0.4% |
| Profit (loss) for the period to be appropriated | 9905 | €411,756 | €413,207 | +€1,451 | +0.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.